marcus evans north america conferences

9th Product Selection & Pipeline Optimization for Generics

Achieving Maximum Portfolio Diversification and Return on Investment through Strategic Partnerships, Agile Product Selection, and Resource Prioritization

14-15 Sep 2016
Embassy Suites Washington D.C. Convention Center - Washington, D.C., United States of America

Why You Should Attend

9th Product Selection & Pipeline Optimization for Generics

Implement actionable tools and strategies to gain a competitive edge in the generics market. The 9th installment of this meeting provides instructions to evaluate In-licensing and Out-Licensing opportunities to shore up pipeline resources and maximize ROI, and to efficiently streamline the changes involved in portfolio integrations through recent company mergers or acquisitions.

Key players in the Generics industry involved in business development, portfolio management, project management, intellectual property and regulatory affairs will discuss tested and proven tactics in forging new business opportunities, selecting the right product portfolio, and driving growth and expansion globally. This conference features a variety of content rich presentations on licensing, mergers & acquisitions, portfolio integrations, pricing pressures, product selection, and portfolio and pipeline optimization, while forging new relationships, identifying potential partners, and capitalizing on new opportunities.

Key Topics

  • Strategize product selection at the front end to enhance pipeline development processes
  • Optimize portfolio management methods in the front end to ensure a robust and lucrative product portfolio
  • Leverage best practices in commercialization strategies to maintain speed to market, enhance resource allocation initiatives and increase ROI
  • Consolidate a Business Development (BD) strategy to optimize portfolio management and resource allocation
  • Develop strategic partnerships to expedite generic drug development
  • Previous Attendees Include

    Vista Pharmaceuticals Inc, Upsher-Smith Laboratories Inc., Apotex Inc., Citron Pharma, Teva API Inc, Impax Laboratories, Perrigo Pharmaceuticals, IGI Labs, Breckenridge Pharma, G&W Laboratories, Dr Reddy's Laboratories, Akorn Inc, Heritage Pharma, Nostrum Laboratories, Renaissance Pharma, Coldstream Labs, Midas Pharmaceuticals Inc, Versapharm, Fresenius Kabi USA, Torrent Pharma Inc, Harris Pharmaceutical, Abon Pharmaceuticals LLC, Auromedics Pharma, Pharmascience Inc, Xellia Pharmaceuticals, West Ward Pharmaceuticals, Sagent Pharmaceuticals Inc, Hi-Tech Pharmacal Co. Inc, Mylan Pharmaceuticals, Amneal Pharmaceuticals, Glenmark Generics Inc USA, Sterimax Inc, Teva Pharmaceuticals

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Partners

    Practical Insights From

    Robert Lionberger, Ph.D.
    Director, Office of Research and Standards
    Office of Generic Drugs CDER, FDA

    Sami Yusuf, Pharm. D., M.S., MBA
    Senior Director, Corporate Development Head of Generic Pipeline
    Upsher-Smith Laboratories, Inc.

    Kurt R. Nielsen, Ph.D.
    Lupin Somerset

    Kumar Kantheti
    Vice President, Portfolio Management
    G&W Laboratories

    Richard A. Hoyt
    Vice President, Business Development and Licensing
    Mallinckrodt Pharmaceuticals

    Mahen Gundecha
    Head, Alliance Management
    Sandoz Inc.

    Gopal Venkatesan
    Vice President, Business Development
    Wockhardt USA LLC

    Sandra Tomassini
    Director, Global Project Management
    Apotex, Inc.

    Click Here For Full Agenda

    Voice of Our Customers
    • "The content of the event was very up to date and well explained. Q+A very interactive." Teva Pharmaceuticals
    • "Relevant and useful topics from industry perspective." Abbott
    • "Terrific chance to connect with other industry traders to exchange ideas and explore solutions to the challenges we all face." OrchidPharma
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Angelica Anselmo

    455 North CityFront Plaza Drive
    9th Floor NBC Tower
    Chicago, IL, 60611

    Fax: 312-894-6304